Hope for new Alzheimer's drug from Saxony-Anhalt
Probiodrug is pushing ahead with the development of its business in the United States
The biopharmaceutical company Probiodrug from Halle/Saale, Saxony-Anhalt, is researching new approaches into fighting Alzheimer's disease. Probiodrug has been listed on the Euronext stock exchange in Amsterdam since 2014. The company has successfully developed a new therapy concept for diabetics in the past.
Since 2007, no new drug has been approved for the treatment of Alzheimer's disease. The medical products currently available only treat the symptoms. "They improve the transmission of signals between the synapses. They don't prevent the neuronal decline, however," explains Konrad Glund. Glund is the co-founder and CEO of the biotechnology company Probiodrug which is based in Halle/Saale in the German federal state of Saxony-Anhalt, a location that the entrepreneur believes to provide excellent conditions for research and development. "The research conditions are very good and they have improved further in recent years. Saxony-Anhalt offers interesting financial instruments and provides start-up financing and investor mediation. It also provides direct project funding."
For more than twelve years, the company has been conducting research into a concept of therapy for treating Alzheimer's disease. The researchers from Saxony-Anhalt have discovered a mechanism through which a normal brain peptide, called amyloid-beta, is chemically changed and therefore advances the disease...
Click here to read the full article: http://lsaurl.de/probio16
---
Probiodrug is based in the German federal state of Saxony-Anhalt, a location that the company believes to provide excellent conditions for research and development and the right financial instruments. It is only one of several flagship companies representing Saxony-Anhalt's competence in biotechnology and pharmaceuticals at BIO International Convention 2016 in San Francisco.
Meet us at booth 1005-03, in the German Pavilion, at BIO 2016 and get to know Germany's biotech region Saxony-Anhalt.
Contact:
Investment and Marketing Corporation Saxony-Anhalt
The economic development agency of the German federal state of Saxony-Anhalt
Tanja Ruedinger
Project Manager International Press & PR
Tel.: 0049 391 5689976
Fax: 0049 391 5689950
E-Mail: tanja.ruedinger@img-sachsen-anhalt
Internet: www.invest-in-saxony-anhalt.com
Investment and Marketing Corporation Saxony-Anhalt (IMG)
IMG is the economic development agency of the German federal state Saxony-Anhalt. IMG staff provides all services related to new business sites. In addition, we are marketing Saxony-Anhalt both nationally and internationally and developing tourism concepts.
We search our site and property database with 250 industrial and trade estates for a location tailored to your needs. We provide competent and individual advice for greenfield and brownfield sites, office properties or production halls. First site information provided within 24 hours. Arrangement of site visits take place following your preliminary selection. We can advise you on public grant programmes for investments, identify potential partners and arrange meetings with them. We identify a point of contact for you with the public authorities, coordinate and carry out negotiations for you on a federal state, state district and municipal level as well as with official bodies and institutions. We were assigned by the Ministry for Science and Economic Affairs of Saxony-Anhalt to guide you as a one-stop agency through the investment process.
Our services are free of charge for you!
Tags:
